We are live on ! Find out more
FCM

Fourpath Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 29.98%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+29.98%
3 Year Est. Return
+72.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$2.97M
Cap. Flow
-$10.8M
Cap. Flow %
-7.46%
Top 10 Hldgs %
48.25%
Holding
148
New
12
Increased
38
Reduced
78
Closed
8

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$530K
2
FJUL icon
FT Vest US Equity Buffer ETF July
FJUL
+$508K
3
GILD icon
Gilead Sciences
GILD
+$351K
4
TGT icon
Target
TGT
+$267K
5
LLY icon
Eli Lilly
LLY
+$238K

Top Sells

Rank Stock Value
1
RWM icon
ProShares Short Russell2000
RWM
+$3.92M
2
SJB icon
ProShares Short High Yield
SJB
+$2.41M
3
SH icon
ProShares Short S&P500
SH
+$2.23M
4
GDX icon
VanEck Gold Miners ETF
GDX
+$1.35M
5
MDT icon
Medtronic
MDT
+$565K

Sector Composition

Rank Sector Weight
1 Energy 16.92%
2 Technology 8.48%
3 Financials 6.92%
4 Healthcare 6.43%
5 Consumer Staples 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IAU icon
1
iShares Gold Trust
IAU
$62.4B
$19.5M 13.54%
464,620
-8,472
-2% -$332K
XOM icon
2
ExxonMobil
XOM
$611B
$15.4M 10.68%
132,458
-110
-0.1% -$11.5K
SJB icon
3
ProShares Short High Yield
SJB
$53.8M
$9.42M 6.53%
550,678
-139,619
-20% -$2.41M
URA icon
4
Global X Uranium ETF
URA
$5.36B
$5.88M 4.08%
204,012
+3,867
+2% +$112K
RWM icon
5
ProShares Short Russell2000
RWM
$114M
$4.52M 3.14%
225,512
-183,911
-45% -$3.92M
GDX icon
6
VanEck Gold Miners ETF
GDX
$21.8B
$4.16M 2.88%
131,538
-47,493
-27% -$1.35M
WMT icon
7
Walmart Inc
WMT
$909B
$3.3M 2.29%
54,857
+11
+0% +$629
AAPL icon
8
Apple
AAPL
$4.9T
$2.72M 1.89%
15,855
-164
-1% -$29.8K
T icon
9
AT&T
T
$152B
$2.33M 1.62%
132,323
-1,469
-1% -$25.1K
SH icon
10
ProShares Short S&P500
SH
$884M
$2.32M 1.61%
48,980
-44,604
-48% -$2.23M
MSFT icon
11
Microsoft
MSFT
$2.93T
$2.22M 1.54%
5,269
-174
-3% -$70.4K
BRK.A icon
12
Berkshire Hathaway Class A
BRK.A
$1.06T
$1.9M 1.32%
3
– –
VZ icon
13
Verizon
VZ
$182B
$1.79M 1.24%
42,610
-657
-2% -$26.5K
AMZN icon
14
Amazon
AMZN
$2.66T
$1.63M 1.13%
9,027
-140
-2% -$23.4K
MPLX icon
15
MPLX
MPLX
$57.9B
$1.62M 1.13%
39,048
– –
BRK.B icon
16
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.52M 1.06%
3,625
– –
CVX icon
17
Chevron
CVX
$373B
$1.46M 1.02%
9,285
+859
+10% +$130K
ENB icon
18
Enbridge
ENB
$124B
$1.45M 1%
39,949
-530
-1% -$18.8K
PM icon
19
Philip Morris
PM
$301B
$1.33M 0.92%
14,512
-212
-1% -$19.5K
SO icon
20
Southern Company
SO
$107B
$1.28M 0.89%
17,791
-286
-2% -$19.7K
DUK icon
21
Duke Energy
DUK
$97.5B
$1.27M 0.88%
13,093
-250
-2% -$23.7K
UNH icon
22
UnitedHealth
UNH
$387B
$1.18M 0.82%
2,382
+10
+0.4% +$5.08K
ABBV icon
23
AbbVie
ABBV
$450B
$1.18M 0.82%
6,458
-2,229
-26% -$384K
TTE icon
24
TotalEnergies
TTE
$181B
$1.13M 0.79%
16,453
-3,960
-19% -$260K
WMB icon
25
Williams Companies
WMB
$89.7B
$1.12M 0.78%
28,858
-611
-2% -$21.7K
1
2 3 4 5

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
AIA
Allied Investment Advisors Billings, Montana $697M AUM 21.33% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return

Fourpath Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Fourpath Capital Management held 148 positions worth $144M, down 2% from $147M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Fourpath Capital Management withdrew a net $10.8M in Q1 2024, closing 8 positions and reducing 78 holdings. Its most notable exit was Medtronic, an estimated $565K position sold in full.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Fourpath Capital Management opened a new position in Bristol-Myers Squibb worth $564K.

  • Fourpath Capital Management's largest Q1 2024 buy was Bristol-Myers Squibb: 10,407 shares worth $564K.
  • Fourpath Capital Management added most to Gilead Sciences in Q1 2024, an estimated $351K increase.
  • Fourpath Capital Management's biggest Q1 2024 reduction was ProShares Short Russell2000, cutting an estimated $3.92M.
  • Fourpath Capital Management fully exited Medtronic in Q1 2024, selling an estimated $565K.
  • Fourpath Capital Management's ten largest holdings make up 48% of its $144M portfolio in Q1 2024.
  • Fourpath Capital Management opened 12 new positions and closed 8 in Q1 2024.
  • Fourpath Capital Management's portfolio value fell 2% quarter-over-quarter to $144M.

Based on Fourpath Capital Management's 13F filing for Q1 2024, filed 7 May 2024.